Skip to content

Medi-Trace Combination Defibrillation & ECG Electrode for Laerdal

by Graphic Controls Corp.

510(k) K955923

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK955923 Date24 Oct 1996ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MKJ
Device Class
Class III
Regulation
21 CFR Part 870.5310
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Medi-Trace Combination Defibrillation & ECG Electrode is a dual-purpose adhesive electrode designed for use with automated external defibrillators (non-wearable) and electrocardiogram (ECG) monitoring. It provides simultaneous defibrillation and ECG signal acquisition, enabling rapid assessment and treatment of cardiac arrest or arrhythmias in emergency settings.

This single-use electrode is intended for professional healthcare providers and first responders, adhering to FDA-substantiated equivalence under 510(k) clearance (K955923). Supplied sterile and packaged individually, it requires no special storage conditions beyond protection from contamination. Compatible with Laerdal defibrillators, it is classified as a Class III medical device under FDA regulation 870.5310.

Other devices from Graphic Controls Corp.

See all devices from Graphic Controls Corp. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Medi-Trace Combination Defibrillation & ECG Electrode, and who is it intended for?

    The Medi-Trace Combination Defibrillation & ECG Electrode is designed for simultaneous defibrillation and ECG monitoring, enabling rapid assessment and treatment of cardiac arrest or arrhythmias in emergency settings. It is specifically intended for professional healthcare providers and first responders, as it combines two critical functions into a single-use adhesive electrode.

  • Is this electrode reusable, or is it meant for single-use only?

    This electrode is explicitly labeled as single-use, meaning it is intended for one-time application only. This design ensures sterility and reduces the risk of cross-contamination in emergency medical scenarios.

  • How should the Medi-Trace Combination Defibrillation & ECG Electrode be stored, and what sterility guarantees does it provide?

    The electrode is supplied sterile and packaged individually, so no special storage conditions are required beyond protecting it from contamination. The sterile packaging ensures it remains uncontaminated until use, making it safe for immediate application in emergency situations.

  • Which defibrillators is this electrode compatible with, and how does that affect its use?

    The Medi-Trace Combination Defibrillation & ECG Electrode is specifically designed for compatibility with Laerdal defibrillators. This targeted compatibility ensures seamless integration with these devices, allowing healthcare providers and first responders to rely on it for accurate ECG monitoring and effective defibrillation during cardiac emergencies.

  • What regulatory pathway was followed for this device’s approval, and what does that mean for its use?

    The device received FDA 510(k) clearance (K955923) under a traditional review pathway, with a decision of *Substantially Equivalent* to a predicate device. This means its safety and performance were compared to an existing approved device, and it was determined to be equivalent in terms of technological characteristics. The clearance confirms it meets FDA standards for use in defibrillation and ECG monitoring.